Paydirt
SP
Insider

Sanjiv Patel

President and CEO

Sanjiv Patel (President and CEO) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Relay Therapeutics, Inc. (RLAY). The largest single filing was $980K of RLAY (48,199 sh × $20.33, as filed), executed Aug 17.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$3.6M
shares × price, as filed
Last traded
Sep 8
Filed Sep 9

Median ADV $74.0M across their filed names

Open performance
Volume by month
$1.8M$881K$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2024 · sells $500KJan 2025 · sells $1.8MFeb 2025 · sells $818KApr 2025 · sells $127KJul 2025 · sells $153KNov 2025 · sells $435KJan 2026 · sells $338KJul 2026 · sells $944KAug 2026 · sells $980KSep 2026 · sells $913K
Buys $0 Sells $7.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 5 filings

Sector per market data · by filing · past 12 months

Most traded names
RLAY Relay Therapeutics, Inc. RLAY · 0 buys · 10 sells 10 filings
Recent filings
RLAYSALE Relay Therapeutics, Inc. View filing → $1.8M
375,000 sh across 3 lots
Exec Jan 21 2025
Filed Jan 23 2025 · 5:30 PM ET
RLAYSALE Relay Therapeutics, Inc. View filing → $500K
100,000 sh × $5.00
Exec Dec 16 2024
Filed Dec 18 2024 · 5:30 PM ET